Advocate

Country: European Union

Language: Maltese

Source: EMA (European Medicines Agency)

Active ingredient:

imidakloprid, moksidektin

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Prodotti kontra l-parassiti, insettiċidi u repellenti

Therapeutic indications:

DogsFor klieb li qed isofru minn, jew huma f'riskju minn infezzjonijiet kawżati minn parassiti diversi:it-trattament u l-prevenzjoni tal-infestazzjoni mill-briegħed (Ctenocephalides felis),trattament tal-qamel li jigdem (Trichodectes canis),trattament ta ' infestazzjoni dudu tal-widna (Otodectes cynotis), sarcoptic mange (ikkawżata minn Sarcoptes scabiei var. canis), 'domodikosis (ikkawżata minn Demodex canis),il-prevenzjoni tal-heartworm disease (L3 u l-larva L4 tad-Dirofilaria immitis),trattament ta jiċċirkola microfilariae (Dirofilaria immitis),il-kura ta' cutaneous dirofilariosis (adulti l-istadji tal-Dirofilaria repens)il-prevenzjoni tal-ġilda dirofilariosis (larva L3 tal-Dirofilaria repens),it-tnaqqis tal jiċċirkola microfilariae (Dirofilaria repens),il-prevenzjoni tal-angiostrongylosis (larva L4 u l-adulti immaturi ta 'Angiostrogylus vasorum),it-trattament ta' Angiostrogylus vasorum u Crenosoma vulpis,il-prevenzjoni tal-spirocercosis (Spirocerca lupi),it-trattament tal-Eucoleus (sin. Capillaria) boehmi (adulti),il-kura ta 'l-għajn worm Thelazia callipaeda (adulti),il-kura ta' infezzjonijiet bl-ħniex gastro-intestinali (larva L4, adulti immaturi u l-adulti tal-Toxocara canis, Ancylostoma caninum u Uncinaria stenocephala, adulti tat-Toxascaris leonina u Trichuris vulpis). Il-prodott jista 'jintuża bħala parti minn strateġija ta' trattament għal dermatite tal-allerġija tal-briegħed (FAD). CatsFor-qtates li jbatu minn, jew huma f'riskju minn infezzjonijiet kawżati minn parassiti diversi:it-trattament u l-prevenzjoni tal-infestazzjoni mill-briegħed (Ctenocephalides felis),trattament ta 'infestazzjoni dudu tal-widna (Otodectes cynotis),it-trattament tal-notoedric mange (Notoedres cati),il-kura ta' l-lungworm Eucoleus aerophilus (sin. Capillaria aerophila) (adulti),il-prevenzjoni tal-lungworm-marda (L3/larva L4 ta'Aelurostrongylus abstrusus),il-kura ta 'l-lungworm Aelurostrongylus abstrusus (adulti),il-kura ta' l-għajn worm Thelazia callipaeda (adulti),il-prevenzjoni tal-heartworm disease (L3 u l-larva L4 tad-Dirofilaria immitis),trattament ta ' infezzjonijiet b'nematodi gastrointestinali (larva L4, adulti immaturi u l-adulti tal-Toxocara cati u Ancylostoma tubaeforme). Il-prodott jista 'jintuża bħala parti minn strateġija ta' trattament għal dermatite tal-allerġija tal-briegħed (FAD). FerretsFor l-inmsa li qed isofru minn, jew huma f'riskju minn infezzjonijiet kawżati minn parassiti diversi:it-trattament u l-prevenzjoni tal-infestazzjoni mill-briegħed (Ctenocephalides felis),il-prevenzjoni tal-heartworm disease (L3 u l-larva L4 tad-Dirofilaria immitis).

Product summary:

Revision: 23

Authorization status:

Awtorizzat

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Informazzjoni aġġornata dwar dan il-prodott mediċinali veterinarju
hija disponibbli fuq is-sit web tal-
Informazzjoni dwar il-Mediċini Veterinarji.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Informazzjoni aġġornata dwar dan il-prodott mediċinali veterinarju
hija disponibbli fuq is-sit web tal-
Informazzjoni dwar il-Mediċini Veterinarji.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 31-01-2024
Public Assessment Report Public Assessment Report Bulgarian 29-01-2024
Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Estonian 31-01-2024
Public Assessment Report Public Assessment Report Estonian 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Latvian 31-01-2024
Public Assessment Report Public Assessment Report Latvian 29-01-2024
Patient Information leaflet Patient Information leaflet Lithuanian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 31-01-2024
Public Assessment Report Public Assessment Report Lithuanian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Romanian 31-01-2024
Public Assessment Report Public Assessment Report Romanian 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

View documents history